BTIG Reiterates Buy on Sophia Genetics, Maintains $8 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 86.2%

Neg 0% Neu 86.2% Pos 0%

BTIG analyst Mark Massaro reiterates Sophia Genetics (NASDAQ:SOPH) with a Buy and maintains $8 price target.

Comments

No comments yet. Be the first!